Synaptophysin is an autoantigen in paraneoplastic neuropathy

Area of Science:

• Neuroimmunology
• Oncology
• Neuropathology

Background:

• Paraneoplastic neurological syndromes (PNS) are immune-mediated disorders triggered by cancer, often involving autoantibodies targeting neuronal components.
• While many autoantigens are known, novel targets continue to be discovered, expanding our understanding of PNS pathogenesis.

Observation:

• A patient with small cell lung cancer and paraneoplastic sensorimotor and autonomic neuropathy presented with serum autoantibodies.
• Immunofluorescence and immunoblotting revealed these antibodies targeted synaptophysin, a synaptic protein, in the cerebellum and myenteric plexus.

Findings:

• The study identified anti-synaptophysin autoantibodies as a novel marker associated with paraneoplastic sensorimotor and autonomic neuropathy in small cell lung cancer.
• These antibodies were specific to patients with PNS and not detected in healthy controls or most small cell lung cancer patients without neurological symptoms.
• The patient's antibodies demonstrated cytotoxicity towards myenteric plexus neurons, suggesting a direct pathogenic role.

Implications:

• Synaptophysin is identified as a new autoantigen in paraneoplastic neurological syndromes, particularly those linked to small cell lung cancer.
• This finding may lead to improved diagnostic tools and targeted therapies for patients with specific paraneoplastic neuropathies.
• Further research into anti-synaptophysin autoimmunity could elucidate mechanisms underlying neuronal damage in PNS.